Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn’s Disease Fistulas

Autor: Sheeva Johnson, Jeffrey S. Hoch, Wissam J. Halabi, Jeffrey Ko, Jan Nolta, Maneesh Dave

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

Crohn’s disease (CD) is an inflammatory bowel disease with increasing incidence and prevalence worldwide. Perianal fistulas are seen in up to 26% of CD patients and are often refractory to medical therapy. Current treatments for CD perianal fistula

Externí odkaz: https://doaj.org/article/43b347ef96164c7aaeef22460376fdc8

Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series

Autor: Arta M. Monjazeb, Kit Tam, Madison McKenny, Wissam J. Halabi, Jun Gong, Rahel Demisse, Ryan Louie, Jingran Ji, Farshid Dayyani, Edward J. Kim, Marwan Fakih, James Liu, Cathy Eng, Sepideh Gholami, May Cho, Neha Damle, Leslie G. Oesterich

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN. 18(7)

Treatment options for locally advanced rectal cancer have continued to consist largely of chemotherapy, chemoradiation, and/or surgical resection. For patients who are unable to undergo these therapeutic modalities or who do not to experience a respo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323a2143b2a9b851ca907a9c96c02191
https://pubmed.ncbi.nlm.nih.gov/32634770

Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer

Autor: Arta M. Monjazeb, Ky Nam Bao Nguyen, Kit Tam, Linda M. Farkas, Wissam J. Halabi, Shannon M. Navarro, Edward J. Kim, Simran Sekhon, Yi Rong, Xiao Zhao, Ruben C Fragoso, Shyam Rao, May Cho, Haixin Huang, Haihui Chen, Megan E. Daly, Richard K. Valicenti, Chengjun Feng

Publikováno v: Practical radiation oncology. 10(5)

Purpose In rectal cancer, the presence of extramesorectal/lateral pelvic lymph node (LPN) is associated with higher risk of locoregional and distant recurrences. LPNs are not typically resected during a standard total mesorectal excision (TME) proced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0c81b9a8795d30aefbb93abe2da5da
https://pubmed.ncbi.nlm.nih.gov/31866577

319 FISTULA HEALING IS LOW AFTER FECAL DIVERSION SURGERY IN PERIANAL CROHN'S DISEASE

Autor: Sheeva Johnson, Jeffrey Ko, Wissam J. Halabi, Jesse L. Stondell, Maneesh Dave

Publikováno v: Gastroenterology. 160:S-886

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47cd12235c29c43cf7645ea8b9978146
https://doi.org/10.1016/s0016-5085(21)02848-1

Morbidity of Diverting Ileostomy for Rectal Cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program

Autor: Joseph C. Carmichael, Fariba Jafari, Steven Mills, Mehraneh D. Jafari, Vinh Q. Nguyen, Alessio Pigazzi, Wissam J. Halabi, Michael J. Stamos

Publikováno v: Jafari, MD; Halabi, WJ; Jafari, F; Nguyen, VQ; Stamos, MJ; Carmichael, JC; et al.(2013). Morbidity of diverting ileostomy for rectal cancer: Analysis of the American College of Surgeons National Surgical Quality Improvement Program. American Surgeon, 79(10), 1034-1039. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/6z2347bx
Scopus-Elsevier
The American surgeon, vol 79, iss 10

There is controversy regarding the potential benefits of diverting ileostomy after low anterior resection (LAR). This study aims to examine the morbidity associated with diverting ileostomy in rectal cancer. A retrospective review of LAR cases was pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2162f7822491571f9d5b0b7923b129e4
https://doi.org/10.1177/000313481307901016